Offer - Urjas Oil for just ₹ 1 X
Lodoz 5 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Lodoz 5 Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Lodoz 5 Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Lodoz 5 Tablet as well, which are listed below. Such side effects of Lodoz 5 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Lodoz 5 Tablet is Safe for pregnant women and Safe for women who are breastfeeding. It is important to know if Lodoz 5 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Lodoz 5 Tablet related warnings section.
Lodoz 5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Asthma, Liver Disease are examples of such conditions. Other contraindications of Lodoz 5 Tablet have been discussed in the sections ahead.
Drug interactions for Lodoz 5 Tablet have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Lodoz 5 Tablet is considered not safe while driving, and is not addictive.
Lodoz 5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Lodoz 5 Tablet safe for pregnant women?
There are no side effects of Lodoz in pregnant women.
Is the use of Lodoz 5 Tablet safe during breastfeeding?
Lodoz is safe for breastfeeding women.
What is the effect of Lodoz 5 Tablet on the Kidneys?
Lodoz may have mild side effects on the kidneys.
What is the effect of Lodoz 5 Tablet on the Liver?
Lodoz is rarely harmful for the liver.
What is the effect of Lodoz 5 Tablet on the Heart?
Lodoz has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Lodoz 5 Tablet unless your doctor advises you to do so -
Is this Lodoz 5 Tablet habit forming or addictive?
Forming a habit of Lodoz 5 Tablet has not been reported.
Interaction between Food and Lodoz 5 Tablet
Lodoz 5 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Lodoz 5 Tablet
Taking Lodoz 5 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 229
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bisoprolol An (bisoprolol fumarate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bisoprolol Sandoz® (bisoprolol fumarate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448